-
1
Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
Published 2019-01-01“…Nevertheless, views on the pathophysiology of depression have evolved notably, and the comprehension of depression as a complex neuroendocrine disorder with important systemic implications has sparked interest in a myriad of novel neuropsychopharmacological approaches. Innovative pharmacological targets beyond monoamines include glutamatergic and GABAergic neurotransmission, brain-derived neurotrophic factor, various endocrine axes, as well as several neurosteroids, neuropeptides, opioids, endocannabinoids and endovanilloids. …”
Get full text
Article -
2
-
3
Tandospirone prevents anesthetic-induced respiratory depression through 5-HT1A receptor activation in rats
Published 2025-01-01Get full text
Article -
4
-
5
-
6
-
7
-
8
-
9
Classification and Characteristics of Pain Associated with Parkinson’s Disease
Published 2016-01-01Get full text
Article -
10
Advances in functional MRI research in bipolar disorder: from the perspective of mood states
Published 2024-02-01Get full text
Article -
11
-
12